RVNC

Revance Therapeutics Stock Price

31.84
0.00 (0.0%)
31.84

Low
22.82

52 Week Range

High
34.62

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Revance Therapeutics Inc RVNC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 31.84 09:28:30
Open Price Low Price High Price Close Price Prev Close
31.84
Bid Price Ask Price Spread News
31.50 32.00 0.50 - -
Trades Volume Avg Volume 52 Week Range
1 1 418,288 22.82 - 34.62
Last Trade Time Type Quantity Stock Price Currency
08:18:36 1 $ 31.84 USD

Revance Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.28B 71.53M 68.75M $ 15.33M $ - -4.85 -6.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 57.69k 2.50%

more financials information »

Revance Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RVNC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week30.1732.0029.9431.14405,3871.675.54%
1 Month29.8532.0027.6929.91380,0091.996.67%
3 Months28.2832.0026.3028.88380,7573.5612.59%
6 Months27.8932.0023.9228.08423,8083.9514.16%
1 Year24.7234.6222.8227.31504,7007.1228.8%
3 Years30.0034.629.8821.38486,7111.846.13%
5 Years13.0037.459.8822.61394,49018.84144.92%

Revance Therapeutics Description

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in research and development of aesthetic and therapeutic products.


Your Recent History
NASDAQ
RVNC
Revance Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.